| Company Name: |
Suzhou Zhixin Biotechnology Co., Ltd.
|
| Tel: |
0512-65118909 18100677375 |
| Email: |
sales@szzxbio.com |
| Products Intro: |
Product Name:HDAC/NAMPT-IN-1
CAS:2898381-63-8
Purity:98%+ Package:1g;10g;100g
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:HDAC/NAMPT-IN-1
CAS:2898381-63-8
Package:50mg;10mg
|
|
| | HDAC/NAMPT-IN-1 Basic information |
| Product Name: | HDAC/NAMPT-IN-1 | | Synonyms: | HDAC/NAMPT-IN-1;Benzoic acid, 4-[[(1H-pyrrolo[3,2-c]pyridin-2-ylcarbonyl)amino]methyl]-, 2-propylhydrazide | | CAS: | 2898381-63-8 | | MF: | C19H21N5O2 | | MW: | 351.4 | | EINECS: | | | Product Categories: | | | Mol File: | 2898381-63-8.mol |  |
| | HDAC/NAMPT-IN-1 Chemical Properties |
| Boiling point | 653.2±55.0 °C(predicted) | | density | 1.262±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 12.55±0.23(predicted) |
| | HDAC/NAMPT-IN-1 Usage And Synthesis |
| Uses | HDAC/NAMPT-IN-1 (compound 39h) is a dual inhibitor of HDAC and NAMPT with IC50 values of 0.72-37081 nM and 1618 nM[1]. | | References | [1] Kairui Yue, et al. HDAC/NAMPT dual inhibitors overcome initial drug-resistance in p53-null leukemia cells. Eur J Med Chem. 2024. DOI:10.1016/j.ejmech.2024.116127 |
| | HDAC/NAMPT-IN-1 Preparation Products And Raw materials |
|